The final analysis including the 24-month evaluation of Xintela's (XINT) clinical study on XSTEM for knee osteoarthritis has now been completed. The results show continued safety, reduction of knee pa ...

Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.

Pediatric dosing expected to begin in Q4 2025Pivotal cohort expected to begin enrolling in Q1 2026BLA submission anticipated in early 2028Part A ...

This valuable study analyzes aging-related chromatin changes through the lens of intra-chromosomal gene correlation length, which is a novel computational metric that captures spatial correlations in ...

A review of current-generation below-the-knee drug-eluting resorbable scaffolds, focusing on their appropriate use and where they are headed next.

For immune cells, the actin cytoskeleton is more than a structural scaffold. Immune cells can migrate to sites of infection ...

Every time a eukaryotic cell divides, it faces a monumental challenge: It must carefully duplicate and divide its genetic ...

Lab-made organoids that mimic reproductive tissues could point to treatments for common conditions such as pre-eclampsia and ...

If Not Me then Who? The Identity and Activism of Black Women during Jim Crow and Apartheid in Jim Crow and apartheid are two ...